SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-008989
Filing Date
2022-05-10
Accepted
2022-05-10 16:17:18
Documents
14
Period of Report
2022-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tlis-20220510.htm   iXBRL 8-K 55902
2 EX-99.1 tlis-ex99_1.htm EX-99.1 142137
3 GRAPHIC img68472451_0.jpg GRAPHIC 2698
  Complete submission text file 0000950170-22-008989.txt   328126

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tlis-20220510_lab.xml EX-101.LAB 13438
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tlis-20220510_pre.xml EX-101.PRE 9928
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tlis-20220510.xsd EX-101.SCH 2483
8 EXTRACTED XBRL INSTANCE DOCUMENT tlis-20220510_htm.xml XML 4709
Mailing Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025 650-433-3000
Talis Biomedical Corp (Filer) CIK: 0001584751 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40047 | Film No.: 22909879
SIC: 3826 Laboratory Analytical Instruments